According to a study by a team of scientists at UT Southwestern, triptans (a class of migraine medications) may help reduce not only pain but also obesity. This was proven by experiments on mice, the results of which are described in an article in the Journal of Experimental Medicine.
Peter O’Donnell Jr. Research leader at the Brain Institute, Dr. Chen Liu says that triptans act on the serotonin 1B (Htr1b) receptor. This receptor has not been well studied before.
As part of a new study, scientists tested six types of prescription triptans in laboratory mice. All animals were obese and fed a high-fat diet for seven weeks.
It turned out that the rats who took the two drugs ate about the same amount of food, while those who took the other four drugs ate less. After 24 days, mice receiving a daily dose of frovatriptan lost an average of 3.6% weight, while those receiving no triptan gained an average of 5.1% kilograms.
News cannot be equated with a doctor’s prescription. Consult an expert before making a decision.
Source: Ferra
